Articles From: Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia to Celanese Announces Acetyl Intermediates Price Increases


2013/5/15
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta, in combination with rituximab for older patients with treatment-naïve chronic lymphocytic leukemia (CLL). This regimen achieved a complete response (CR) rate of 19 percent and an overall response rate (ORR) of 97 percent, with estimated progression-free survival (PFS) at 24 months of 93 percent.
Sign-up for Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia investment picks
2013/5/15
BOGOTA, Colombia , May 15, 2013 /PRNewswire/ -- Ecopetrol S.A. (NYSE: EC; BVC: ECOPETROL; TSX: ECP) announces that it submitted the highest bids for three exploratory blocks in the 11 th Bidding Round carried out yesterday by the Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis (National Agency of Petroleum, Natural Gas and Biofuels, or ANP) of Brazil in Rio de Janeiro .
Sign-up for Ecopetrol Submitted the Highest Bids for Three Blocks in the Brazil Bidding Round investment picks
2013/5/15
Merck & Co., Inc. priced today a $6.5 billion public offering of senior unsecured notes.
Sign-up for Merck Prices $ 6.5 Billion Debt Offering investment picks
2013/5/15
A federal judge reinstated a $203 million penalty against Wells Fargo & Co.
Sign-up for Judge Reinstates $203 Million Penalty Against Wells Fargo in California Overdraft-Fee Case -Reuters investment picks
2013/5/15
At least two pay TV operators, including cable giant Time Warner Cable Inc. , are weighing an investment in Hulu as the online video site considers a range of strategic options, according to people familiar with the matter.
Sign-up for At Least Two Pay TV Operators Circling Hulu investment picks
2013/5/15
DDR Corp.
Sign-up for DDR to Buy Shopping Centers in $1.46 Billion Deal investment picks
2013/5/15
--Federal judge suspended environmental licenses for Comperj refinery project --Petrobras, environmental regulators Ibama and Inea to appeal ruling Wednesday --Comperj refinery expected to start processing crude oil in April 2015 RIO DE JANEIRO --Brazilian environmental regulators will join state-run energy giant Petroleo Brasileiro (PBR, PETR4.BR) in appealing an injunction that halted work on a major refinery project in Rio de Janeiro state.
Sign-up for Petrobras, Regulators to Appeal Halt on Refinery Work investment picks
2013/5/15
SAO PAULO , May 15, 2013 /PRNewswire/ -- Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (BM&FBovespa: SBSP3; NYSE: SBS), one of the largest water and sewage service provider in the world based on the number of customers, hereby announces that on May 15, 2013 , filed its annual report on Form 20-F for the fiscal year ended December 31, 2012 (the "2012 Annual Report") with the Securities and Exchange Commission (the "SEC"). The 2012 Annual Report can be accessed by visiting either the SEC's website at www.sec.gov or the Company's website.
Sign-up for SABESP Files its 20-F with the SEC investment picks
2013/5/15
http://media.marketwire.com/attachments/200902/502154_JDSU.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1018041&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for JDSU Repurchases 1% Senior Convertible Notes Due 2026 at the Option of Holders investment picks
2013/5/15
Enrollment in Phase 1 Clinical Trials of ABT-199 in Chronic Lymphocytic Leukemia Continues NORTH CHICAGO, Ill.
Sign-up for AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting investment picks
2013/5/15
Enerplus to Present at the UBS Global Oil & Gas Conference - Austin Canada NewsWire CALGARY , May 15, 2013 /CNW/ - Enerplus Corporation ("Enerplus") (TSX: ERF) (NYSE: ERF) is pleased to advise that Mr.
Sign-up for Enerplus to Present at the UBS Global Oil & Gas Conference - Austin investment picks
2013/5/15
--Federal judge suspended environmental licenses for Comperj refinery project --Petrobras, environmental regulators Ibama and Inea to appeal ruling Wednesday --Comperj refinery expected to start processing crude oil in April 2015 RIO DE JANEIRO --Brazilian environmental regulators will join state-run energy giant Petroleo Brasileiro (PBR, PETR4.BR) in appealing an injunction that halted work on a major refinery project in Rio de Janeiro state.
Sign-up for Brazil's Petrobras, Regulators to Appeal Halt on Refinery Work investment picks
2013/5/15
SAN FRANCISCO (MarketWatch) -- Billionaire investor Carl Icahn had a good first quarter, based on his latest 13F filing with the SEC.
Sign-up for PULSE: Carl Icahn's excellent first quarter investment picks
2013/5/15
Soros Fund Management LLC disposed of stakes in banking giants J.P. Morgan Chase & Co.
Sign-up for Soros Fund Cuts Some Big Banks investment picks
2013/5/15
Positive results from two early-stage studies of drugs from Bristol-Myers Squibb Co.
Sign-up for Pair of Studies Show Power of Immune System to Fight Cancer investment picks
2013/5/15
BOSTON, May 15, 2013 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Gerald P.
Sign-up for ZIOPHARM Announces Poster Presentation at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting investment picks
2013/5/15
NEW YORK , May 15, 2013 /PRNewswire/ --
Sign-up for Spanish Broadcasting System's WSKQ-FM Mega 97.9FM and WPAT-FM 93.1FM Amor leaders in the tri-state area in New York investment picks
2013/5/15
SAN FRANCISCO (MarketWatch) — Cisco Systems Inc. shares jumped after hours Wednesday after the network equipment maker reported quarterly earnings that topped Wall Street estimates.
Sign-up for Cisco, Tesla shares jump after hours investment picks
2013/5/15
Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 7 p.m. EDT (6 p.m. CDT) on Sunday, June 2, 2013, to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Sign-up for Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights investment picks
2013/5/15
Nelson Peltz's Trian Fund Management LP reported no position in MeadWestvaco Corp.
Sign-up for Trian Fund Shows No Stake in MeadWestvaco, Cuts State Street Holding investment picks
2013/5/15
PFSweb, Inc. (Nasdaq: PFSW) , an international provider of end-to-end eCommerce solutions, today announced that, after discussions with representatives of Privet Fund LP, the Company’s Board of Directors (the “Board”) has voted to appoint Benjamin Rosenzweig as a director of the Board effective immediately.
Sign-up for PFSweb to Appoint Benjamin Rosenzweig to Board of Directors investment picks
2013/5/15
SAN DIEGO , May 15, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that clinical data from a Phase 1b trial of PEGPH20 (PEGylated Recombinant Human Hyaluronidase), an investigational new biologic, in combination with gemcitabine for treatment of patients with stage IV metastatic pancreatic cancer will be presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting.
Sign-up for Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting investment picks
2013/5/15
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical data on Iclusig ® (ponatinib) and AP26113, its investigational inhibitor of anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR) and c-ros oncogene (ROS1), will be presented at the Annual Meeting of the American Society of Clinical Oncology being held in Chicago, May 31 to June 4, 2013.
Sign-up for ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting investment picks
2013/5/15
WASHINGTON-The Senate voted Wednesday to give the main agency charged with implementing the 2010 health care law its first confirmed leader in seven years.
Sign-up for Senate Confirms Tavenner as Head of Medicare-Medicaid Agency investment picks
2013/5/15
MDA's advanced technology solutions to be used on telecommunication satellite Canada NewsWire RICHMOND , BC, May 15, 2013 /CNW/ - MacDonald, Dettwiler and Associates Ltd.
Sign-up for MDA's advanced technology solutions to be used on telecommunication satellite investment picks
2013/5/15
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response THOUSAND OAKS, Calif.
Sign-up for New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer investment picks
2013/5/15
THOUSAND OAKS, Calif.
Sign-up for Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting investment picks
2013/5/15
Company Also Announces Adoption of Annual Dividend Policy BEIJING , May 15, 2013 /PRNewswire-FirstCall/ -- NetEase, Inc. (NASDAQ: NTES) , one of China 's leading Internet and online game services providers, today announced its unaudited financial results for the first quarter ended March 31, 2013 .
Sign-up for NetEase Reports First Quarter 2013 Unaudited Financial Results investment picks
2013/5/15
Concho Resources Inc. (NYSE: CXO) ("Concho" or the "Company") today announced that it has appointed Will Giraud as the Company’s Senior Vice President and Chief Commercial Officer.
Sign-up for Concho Resources Expands Management Team investment picks
2013/5/15
Celanese Corporation (NYSE: CE) , a global technology and specialty materials company, will increase list and off-list selling prices by these amounts for the following products effective immediately, or as contracts allow.
Sign-up for Celanese Announces Acetyl Intermediates Price Increases investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia to Celanese Announces Acetyl Intermediates Price Increases
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity